Hemiarch vs Extended Arch in Type 1 Aortic Dissection
Key facts
- Who runs it
- Ottawa Heart Institute Research Corporation
- Where
- Canada5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 30 Jul 2024
- Expected to end
- 31 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hemiarch repair
- Extended arch repair
- Record updated
- 28 September 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Emergent surgical repair of Acute DeBakey Type 1 aortic dissection
- Age >18 years and <70 years
- Operating surgeon believes that both surgeries could be safe and effective
Who cannot take part
- Previous cardiac surgery with sternotomy or thoracic endograft placement
- Aortic arch diameter > 6cm in which a concomitant arch replacement is judged necessary
- History of cirrhosis
- Metastatic malignancy
- History of chronic renal failure (baseline eGFR < 50)
- Hemodynamic instability/shock defined as systolic BP < 90 mm Hg
- Procedures deemed to be "salvage operations" where the patient is unlikely to survive hospital discharge
- GCS < 8 for more than 6 hours
- Pregnancy
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
HEADSTART is a prospective, open-label, non-blinded, multicenter, randomized controlled trial that compares a composite of mortality and re-intervention in patients undergoing hemiarch and extended arch repair for acute DeBakey type 1 aortic dissection. Eligible patients will be randomized to one or the other surgical strategy and clinical and imaging outcome data will be collected over a 3 year follow up period.
The 2 groups in the trial
- Hemiarch repairExisting treatment, for comparison
Standard hemiarch repair with open distal anastomosis in the proximal arch without replacement of the head vessels.
- Extended arch repairExisting treatment, for comparison
Ascending aortic and arch replacement with or without head vessel re-implantation and single TEVAR device placement within 1 week.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Hemiarch vs Extended Arch in Aortic Dissection - a SystemaTic Analysis by Randomized Trial (HEADSTART)
- Criteria questions
- Built from NCT03885635, who can take part
- Publications
- Hemiarch versus extended arch repair for acute type A dissection: Results from a multicenter national registry.The Journal of thoracic and cardiovascular surgery, 2024
- Record updated
- 28 September 2026